Hempalta Statistics

Total Valuation

Hempalta has a market cap or net worth of CAD 4.27 million. The enterprise value is 5.96 million.

Market Cap	4.27M
Enterprise Value	5.96M

Important Dates

The last earnings date was Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Hempalta has 94.94 million shares outstanding. The number of shares has increased by 90.70% in one year.

Current Share Class	94.94M
Shares Outstanding	94.94M
Shares Change (YoY)	+90.70%
Shares Change (QoQ)	+3.88%
Owned by Insiders (%)	20.42%
Owned by Institutions (%)	28.10%
Float	74.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.87
PB Ratio	2.15
P/TBV Ratio	2.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.88
EV / Sales	12.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.42

Financial Position

The company has a current ratio of 0.45, with a Debt / Equity ratio of 0.94.

Current Ratio	0.45
Quick Ratio	0.25
Debt / Equity	0.94
Debt / EBITDA	n/a
Debt / FCF	-0.76
Interest Coverage	-38.90

Financial Efficiency

Return on equity (ROE) is -201.41% and return on invested capital (ROIC) is -38.14%.

Return on Equity (ROE)	-201.41%
Return on Assets (ROA)	-36.29%
Return on Invested Capital (ROIC)	-38.14%
Return on Capital Employed (ROCE)	-99.18%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	14
Asset Turnover	0.09
Inventory Turnover	3.39

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.57% in the last 52 weeks. The beta is 0.65, so Hempalta's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	-68.57%
50-Day Moving Average	0.06
200-Day Moving Average	0.06
Relative Strength Index (RSI)	30.43
Average Volume (20 Days)	13,176

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hempalta had revenue of CAD 481,723 and -6.79 million in losses. Loss per share was -0.07.

Revenue	481,723
Gross Profit	-573,546
Operating Income	-3.20M
Pretax Income	-6.85M
Net Income	-6.79M
EBITDA	-2.94M
EBIT	-3.20M
Loss Per Share	-0.07

Full Income Statement

Balance Sheet

The company has 175,904 in cash and 1.86 million in debt, giving a net cash position of -1.69 million or -0.02 per share.

Cash & Cash Equivalents	175,904
Total Debt	1.86M
Net Cash	-1.69M
Net Cash Per Share	-0.02
Equity (Book Value)	1.99M
Book Value Per Share	0.02
Working Capital	-469,093

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.16 million and capital expenditures -302,774, giving a free cash flow of -2.47 million.

Operating Cash Flow	-2.16M
Capital Expenditures	-302,774
Free Cash Flow	-2.47M
FCF Per Share	-0.03

Full Cash Flow Statement

Margins

Gross Margin	-119.06%
Operating Margin	-664.91%
Pretax Margin	-1,421.79%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Hempalta does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-90.70%
Shareholder Yield	n/a
Earnings Yield	-159.03%
FCF Yield	-57.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 22, 2024. It was a reverse split with a ratio of 0.5882353.

Last Split Date	Mar 22, 2024
Split Type	Reverse
Split Ratio	0.5882353

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a